If approved, ABBV-951 could be an alternative to oral therapy – whose efficacy tends to fall off over time – as well as sustained delivery approaches such as AbbVie's own Duopa, a form of ...

AbbVie already sells another long-acting treatment called Duopa, which delivers carbidopa and levodopa in an intestinal gel form via a gastric tube and pump, but that requires a surgical procedure ...